AST SpaceMobile (AST) already has five of its BlueBird high-capacity broadband satellites in orbit, and has strong ...

Known as Zynteglo in Europe where it is approved to treat the rare blood disorder beta-thalassemia, the gene therapy has been given the all-clear by bluebird’s scientists after reviewing the ...

With the pricing situation 'untenable' in Europe, bluebird will wind down its operations in the 'broken' market Bluebird’s difficulties with commercializing its gene therapies began in Europe ...